FILTER

Refine your search with the following facets to narrow down your results.

4 Current news of Paladin Labs

SpePharm announces the acquisition of Savene from TopoTarget

04-Mar-2010 - SpePharm Holding, BV announced the acquisition of the worldwide (with the exception of North and South America) rights to Savene® from TopoTarget A/S. As part of the acquisition SpePharm will also take on the European sales force of TopoTarget. Savene®, which has been marketed by TopoTarget since ...

Investment oncology orphan drugs +2

IMBiotechnologies Ltd completes purchase of 'Tumor Starvation Technology' from Paladin Labs Inc.

18-Aug-2009 - IMBiotechnologies Ltd announced that the Company has completed purchase of all assets related to the Occlusin(R) tumor starvation technology from Paladin Labs Inc. In addition to the cash payment provided to purchase the technology, Paladin will receive a one time milestone payment on first sale ...

kidney cancer liver cancer medical devices +3

Isotechnika Pharma announces the closing of its partnership with Paladin Labs

22-Jun-2009 - Isotechnika Pharma Inc. announced that the previously announced court supervised plan of arrangement with Paladin Labs Inc. has been completed. The Arrangement creates a strategic partnership between Isotechnika Pharma and Paladin for the commercialization of voclosporin, Isotechnika's ...

bases inhibitors South Africa

Nuvo licenses topical pain product from Paladin

02-Jun-2008 - Nuvo Research Inc. announced that it has licensed the exclusive rights from Paladin Labs Inc.to develop and commercialize a novel topical pain formulation with the potential to treat inflammatory and neuropathic pain conditions. The formulation is in the pre-clinical formulation development stage ...

neuropathic pain pain South Africa